Do you want to easily connect medicinal products, off-target pharmacology, and adverse events? Check the new version of #SafetyVista.
Request access for a trial period at #info@chemotargets.com
Detecting true drug-safety signals from post-marketing spontaneous reports is still a difficult task, subject to multiple biases. With #SafetyVista you can assess how reporting bias affects signal detection.
Contact us for a demo trial at ๐ info@chemotargets.com.
#SafetyVista (chemotargets.com/safetyvista/) is the ultimate assistant to detect and analyse safety signals from #post-marketing data, link them to #pre-clinical and #clinical data, and compare them across therapeutic modalities aiming at the same target.
More info ๐ chemotargets.com/contact/
New #SafetyVista version โจ Augmented Safety Intelligence. Proactive Pharmacovigilance.
SV offers now a set of unique analytics tools to assist in the detection, analysis and forecast of drug safety signals in both global & stratified patient (sub)populations.
Interested? ๐ info@chemotargets.com
This week, our representive #Nikola_Panajotovikj, is attending the 2025 #REMEDi4ALL Hackathon. He will present how #SafetyVista (safety-vista.com) can be used to explore postmarketing drug safety data and drug-target affinities.๐
๐ remedi4all.org/event/2025-r...
A new AI-powered version of #SafetyVista has just been released, now including 2M+ LLM-assisted drug-safety data points from 25K clinical trials and 2K congress abstracts. ๐
๐ safety-vista.com
#DrugSafety #SignalDetection #LLMs #MLmodeling #pharmacovigilance